Practical Patient Care Weekly
Practical Patient Care
Your one stop, leading multi-platform news source for the global healthcare sector.
Welcome to another edition of the Practical Patient Care newsletter!
Discover the latest insights and analyses from the global healthcare market over the past week, brought to you by Practical Patient Care
AISAP , an Israeli medical technology company, has received FDA 510(k) clearance for its AI-powered AISAP Cardio point-of-care ultrasound (POCUS) software platform.
Thrilled to share that AISAP , an innovative Israeli medical technology company, has received FDA 510(k) clearance for its AI-powered AISAP Cardio point-of-care ultrasound (POCUS) software platform!
This cloud-based system integrates four diagnosis modules and eight key measurements to provide rapid, accurate analyses of cardiac conditions. Designed for clinicians with basic scanning skills, AISAP Cardio can diagnose up to 90% of common cardiac parameters within minutes.
With a proven sensitivity and specificity of 93% for major valve diseases, this platform is set to revolutionize patient care. As CEO Adiel Am-Shalom states, it’s all about transforming healthcare at the point of care!
MultiCare Health System is taking a significant leap forward in cancer care by implementing Azra AI 's cutting-edge oncology platform.
This collaboration aims to revolutionize cancer care by enabling rapid identification of cancer diagnoses through real-time analysis of pathology and radiology reports. Care teams can now reach out to newly diagnosed patients within hours, significantly reducing treatment delays. The platform also minimizes the risk of missed incidental findings by identifying high-risk patients from screening reports.
By automating manual tasks, healthcare staff can focus more on patient care, enhancing the overall experience. As John Marshall , CEO of Azra AI , states, this partnership showcases AI's potential to enable earlier interventions and improve survival rates in cancer care. This collaboration between MultiCare and Azra AI demonstrates the transformative power of AI in healthcare, promising significant benefits for both patients and healthcare professionals in the ongoing fight against cancer.
Exciting news in women's healthcare! GE医疗 and UC UC San Diego School of Medicine have joined forces to revolutionize pelvic imaging for women.
This collaboration aims to develop advanced MRI protocols and educational resources to improve the diagnosis and management of female pelvic conditions, with a focus on enhancing visualization of endometriosis and ovarian cancer.
Dr. Rebecca Rakow-Penner from UCSD will lead this ground-breaking project, which includes the creation of training materials for GE HealthCare MRI users worldwide. By empowering clinicians with better decision-making tools, this partnership seeks to bridge a critical gap in women's healthcare. Ultimately, the goal is to democratize advanced imaging techniques and elevate the standard of care for women, addressing the often misunderstood and understudied area of female pelvic health.
领英推荐
Carilion Clinic is set to enhance its services by adopting 飞利浦 innovative cardiovascular solutions at the new Crystal Spring Tower facility.
With 11 specialized Philips interventional suites, physicians will be equipped to treat complex cardiovascular conditions closer to home, optimizing both clinical and operational performance.
Marguerite Underwood, Vice President of the Carilion Clinic Cardiovascular Institute, stated, “At Carilion Clinic, we are committed to improving the health of the communities we serve. Working with Philips ensures that we will be able to set the standard in cardiovascular care, not only today, but well into the future.”
This partnership underscores Carilion's dedication to providing world-class technology and exceptional care for its patients.
美敦力 has reached a significant milestone with the FDA 's approval of expanded magnetic resonance imaging (MRI) labeling for its deep brain stimulation (DBS) systems.
This approval allows for extended active scan times, enhancing diagnostic and functional assessment options for patients.
Dr. Ashwini Sharan, Chief Medical Officer of Medtronic Neuromodulation, stated, “We know that nearly 70 percent of all DBS-eligible patients are estimated to require an MRI as part of their essential care. Only Medtronic DBS systems can continue therapy ON in bipolar mode, under certain conditions, while a patient is having an MRI scan.” This unique capability ensures that patients can receive necessary imaging without interrupting their therapy.
Amaza Reitmeier, Vice President and General Manager of Medtronic Brain Modulation, added, “Patients with movement disorders have debilitating tremors that often impact their ability to physically engage in everyday moments, as well as medical treatments that require stillness like an MRI. This updated labelling is another example of our unwavering commitment to enabling personalized patient care, with the goal of many more patient lives transformed with DBS therapy.”
This expanded MRI labelling not only improves patient access to essential imaging but also reinforces Medtronic's leadership in providing innovative solutions for individuals with neurological disorders.
To have a story featured on next week's newsletter, or require press and marketing support you can contact our team directly...
Editorial Enquiries - [email protected]
Press & Marketing support - [email protected]
Thanks for reading; we hope you enjoyed it.
Until next week.